Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)

China · Delayed Price · Currency is CNY

19.19

+0.47 (2.51%)

Aug 25, 2026, 1:45 PM CST

-17.89% (1Y)

Market Cap	12.42B -19.9%
Revenue (ttm)	4.45B -6.0%
Net Income	689.35M -29.5%
EPS	1.04 -30.0%
Shares Out	663.61M
PE Ratio	18.01
Forward PE	14.33
Dividend	0.46 (2.40%)
Ex-Dividend Date	May 20, 2026

Volume	9,065,414
Open	18.91
Previous Close	18.72
Day's Range	18.79 - 19.35
52-Week Range	17.30 - 23.58
Beta	0.29
Analysts	Hold
Price Target	23.05 (+20.12%)
Earnings Date	Aug 25, 2026

About SHA:600529

Shandong Pharmaceutical Glass Co.Ltd engages in research and development, production, and sale of various pharmaceutical glass packaging products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection vial comprising type I/II/III. It also provides tubular glass products, such as glass tubes for pharma use, other tubular bottle with screw neck finish,... [Read more]

Industry Packaging & Containers

Sector Consumer Discretionary

Founded 1970

Employees 6,775

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600529

Full Company Profile

Financial Performance

In 2025, SHA:600529's revenue was 4.47 billion, a decrease of -8.78% compared to the previous year's 4.90 billion. Earnings were 689.63 million, a decrease of -26.87%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 600529 stock is "Hold." The 12-month stock price target is ¥23.05, which is an increase of 20.12% from the latest price.

Price Target

¥23.05

(20.12% upside)

Analyst Consensus: Hold

Stock Forecasts